Global and Japan Human Rabies Immune Globulin (HRIG) Market Insights, Forecast to 2031

Report ID: 1024037 | Published Date: Jan 2025 | No. of Page: 140 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Rabies Immune Globulin (HRIG) Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type
        1.2.2 200IU
        1.2.3 500IU
    1.3 Market by Application
        1.3.1 Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application
        1.3.2 Category II Exposure
        1.3.3 Category III Exposure
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Human Rabies Immune Globulin (HRIG) Market Size, Estimates and Forecasts
        2.1.1 Global Human Rabies Immune Globulin (HRIG) Revenue 2016-2027
        2.1.2 Global Human Rabies Immune Globulin (HRIG) Sales 2016-2027
    2.2 Global Human Rabies Immune Globulin (HRIG), Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Human Rabies Immune Globulin (HRIG) Historical Market Size by Region (2016-2021)
        2.3.1 Global Human Rabies Immune Globulin (HRIG) Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Human Rabies Immune Globulin (HRIG) Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Human Rabies Immune Globulin (HRIG) Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Region (2022-2027)
        2.4.2 Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Region (2022-2027)

3 Global Human Rabies Immune Globulin (HRIG) Competitor Landscape by Players
    3.1 Global Top Human Rabies Immune Globulin (HRIG) Manufacturers by Sales
        3.1.1 Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturer (2016-2021)
        3.1.2 Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Human Rabies Immune Globulin (HRIG) Manufacturers by Revenue
        3.2.1 Key Human Rabies Immune Globulin (HRIG) Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (2016-2021)
        3.2.3 Global Human Rabies Immune Globulin (HRIG) Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Human Rabies Immune Globulin (HRIG) Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Human Rabies Immune Globulin (HRIG) Revenue in 2020
        3.2.6 Global Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Human Rabies Immune Globulin (HRIG) Price by Manufacturers
    3.4 Global Human Rabies Immune Globulin (HRIG) Manufacturing Base Distribution, Product Types
        3.4.1 Human Rabies Immune Globulin (HRIG) Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Human Rabies Immune Globulin (HRIG) Product Type
        3.4.3 Date of International Manufacturers Enter into Human Rabies Immune Globulin (HRIG) Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Human Rabies Immune Globulin (HRIG) Market Size by Type (2016-2021)
        4.1.1 Global Human Rabies Immune Globulin (HRIG) Sales by Type (2016-2021)
        4.1.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2016-2021)
        4.1.3 Human Rabies Immune Globulin (HRIG) Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Human Rabies Immune Globulin (HRIG) Market Size Forecast by Type (2022-2027)
        4.2.1 Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Type (2022-2027)
        4.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Type (2022-2027)
        4.2.3 Human Rabies Immune Globulin (HRIG) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Human Rabies Immune Globulin (HRIG) Market Size by Application (2016-2021)
        5.1.1 Global Human Rabies Immune Globulin (HRIG) Sales by Application (2016-2021)
        5.1.2 Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2016-2021)
        5.1.3 Human Rabies Immune Globulin (HRIG) Price by Application (2016-2021)
    5.2 Human Rabies Immune Globulin (HRIG) Market Size Forecast by Application (2022-2027)
        5.2.1 Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Application (2022-2027)
        5.2.2 Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Application (2022-2027)
        5.2.3 Global Human Rabies Immune Globulin (HRIG) Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
    6.1 Japan Human Rabies Immune Globulin (HRIG) Market Size YoY Growth 2016-2027
        6.1.1 Japan Human Rabies Immune Globulin (HRIG) Sales YoY Growth 2016-2027
        6.1.2 Japan Human Rabies Immune Globulin (HRIG) Revenue YoY Growth 2016-2027
        6.1.3 Japan Human Rabies Immune Globulin (HRIG) Market Share in Global Market 2016-2027
    6.2 Japan Human Rabies Immune Globulin (HRIG) Market Size by Players (International and Local Players)
        6.2.1 Japan Top Human Rabies Immune Globulin (HRIG) Players by Sales (2016-2021)
        6.2.2 Japan Top Human Rabies Immune Globulin (HRIG) Players by Revenue (2016-2021)
    6.3 Japan Human Rabies Immune Globulin (HRIG) Historic Market Review by Type (2016-2021)
        6.3.1 Japan Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2016-2021)
        6.3.2 Japan Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2016-2021)
        6.3.3 Japan Human Rabies Immune Globulin (HRIG) Price by Type (2016-2021)
    6.4 Japan Human Rabies Immune Globulin (HRIG) Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 Japan Human Rabies Immune Globulin (HRIG) Sales Forecast by Type (2022-2027)
        6.4.2 Japan Human Rabies Immune Globulin (HRIG) Revenue Forecast by Type (2022-2027)
        6.4.3 Japan Human Rabies Immune Globulin (HRIG) Price Forecast by Type (2022-2027)
    6.5 Japan Human Rabies Immune Globulin (HRIG) Historic Market Review by Application (2016-2021)
        6.5.1 Japan Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2016-2021)
        6.5.2 Japan Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2016-2021)
        6.5.3 Japan Human Rabies Immune Globulin (HRIG) Price by Application (2016-2021)
    6.6 Japan Human Rabies Immune Globulin (HRIG) Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 Japan Human Rabies Immune Globulin (HRIG) Sales Forecast by Application (2022-2027)
        6.6.2 Japan Human Rabies Immune Globulin (HRIG) Revenue Forecast by Application (2022-2027)
        6.6.3 Japan Human Rabies Immune Globulin (HRIG) Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Human Rabies Immune Globulin (HRIG) Market Size YoY Growth 2016-2027
    7.2 North America Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
        7.2.1 North America Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021)
        7.2.2 North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021)
        7.2.3 United States
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Region
        8.2.1 Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2016-2021)
        8.2.2 Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia

9 Europe
    9.1 Europe Human Rabies Immune Globulin (HRIG) Market Size YoY Growth 2016-2027
    9.2 Europe Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
        9.2.1 Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021)
        9.2.2 Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Human Rabies Immune Globulin (HRIG) Market Size YoY Growth 2016-2027
    10.2 Latin America Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
        10.2.1 Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021)
        10.2.2 Latin America Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Market Facts & Figures by Country
        11.2.1 Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 CSL Behring
        12.1.1 CSL Behring Corporation Information
        12.1.2 CSL Behring Description and Business Overview
        12.1.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 CSL Behring Human Rabies Immune Globulin (HRIG) Products Offered
        12.1.5 CSL Behring Recent Development
    12.2 Grifols
        12.2.1 Grifols Corporation Information
        12.2.2 Grifols Description and Business Overview
        12.2.3 Grifols Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Grifols Human Rabies Immune Globulin (HRIG) Products Offered
        12.2.5 Grifols Recent Development
    12.3 Sanofi
        12.3.1 Sanofi Corporation Information
        12.3.2 Sanofi Description and Business Overview
        12.3.3 Sanofi Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Sanofi Human Rabies Immune Globulin (HRIG) Products Offered
        12.3.5 Sanofi Recent Development
    12.4 Sichuan Yuanda Shuyang
        12.4.1 Sichuan Yuanda Shuyang Corporation Information
        12.4.2 Sichuan Yuanda Shuyang Description and Business Overview
        12.4.3 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Products Offered
        12.4.5 Sichuan Yuanda Shuyang Recent Development
    12.5 CNBG
        12.5.1 CNBG Corporation Information
        12.5.2 CNBG Description and Business Overview
        12.5.3 CNBG Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 CNBG Human Rabies Immune Globulin (HRIG) Products Offered
        12.5.5 CNBG Recent Development
    12.6 Kamada
        12.6.1 Kamada Corporation Information
        12.6.2 Kamada Description and Business Overview
        12.6.3 Kamada Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Kamada Human Rabies Immune Globulin (HRIG) Products Offered
        12.6.5 Kamada Recent Development
    12.7 CBPO
        12.7.1 CBPO Corporation Information
        12.7.2 CBPO Description and Business Overview
        12.7.3 CBPO Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 CBPO Human Rabies Immune Globulin (HRIG) Products Offered
        12.7.5 CBPO Recent Development
    12.8 Shuanglin Bio
        12.8.1 Shuanglin Bio Corporation Information
        12.8.2 Shuanglin Bio Description and Business Overview
        12.8.3 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Shuanglin Bio Human Rabies Immune Globulin (HRIG) Products Offered
        12.8.5 Shuanglin Bio Recent Development
    12.9 Weiguang Bio
        12.9.1 Weiguang Bio Corporation Information
        12.9.2 Weiguang Bio Description and Business Overview
        12.9.3 Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Weiguang Bio Human Rabies Immune Globulin (HRIG) Products Offered
        12.9.5 Weiguang Bio Recent Development
    12.10 Shanghai RAAS
        12.10.1 Shanghai RAAS Corporation Information
        12.10.2 Shanghai RAAS Description and Business Overview
        12.10.3 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Shanghai RAAS Human Rabies Immune Globulin (HRIG) Products Offered
        12.10.5 Shanghai RAAS Recent Development
    12.11 CSL Behring
        12.11.1 CSL Behring Corporation Information
        12.11.2 CSL Behring Description and Business Overview
        12.11.3 CSL Behring Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 CSL Behring Human Rabies Immune Globulin (HRIG) Products Offered
        12.11.5 CSL Behring Recent Development
    12.12 VINS
        12.12.1 VINS Corporation Information
        12.12.2 VINS Description and Business Overview
        12.12.3 VINS Human Rabies Immune Globulin (HRIG) Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 VINS Products Offered
        12.12.5 VINS Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Human Rabies Immune Globulin (HRIG) Industry Trends
    13.2 Human Rabies Immune Globulin (HRIG) Market Drivers
    13.3 Human Rabies Immune Globulin (HRIG) Market Challenges
    13.4 Human Rabies Immune Globulin (HRIG) Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Human Rabies Immune Globulin (HRIG) Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of 200IU
    Table 3. Major Manufacturers of 500IU
    Table 4. Global Human Rabies Immune Globulin (HRIG) Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Human Rabies Immune Globulin (HRIG) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Human Rabies Immune Globulin (HRIG) Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Regions (2016-2021)
    Table 8. Global Human Rabies Immune Globulin (HRIG) Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Human Rabies Immune Globulin (HRIG) Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Human Rabies Immune Globulin (HRIG) Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Human Rabies Immune Globulin (HRIG) Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Human Rabies Immune Globulin (HRIG) Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Human Rabies Immune Globulin (HRIG) Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Human Rabies Immune Globulin (HRIG) Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Human Rabies Immune Globulin (HRIG) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Human Rabies Immune Globulin (HRIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Immune Globulin (HRIG) as of 2020)
    Table 20. Key Manufacturers Human Rabies Immune Globulin (HRIG) Price (2016-2021) (US$/Unit)
    Table 21. Human Rabies Immune Globulin (HRIG) Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Rabies Immune Globulin (HRIG) Product Type
    Table 23. Date of International Manufacturers Enter into Human Rabies Immune Globulin (HRIG) Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Rabies Immune Globulin (HRIG) Sales by Type (2016-2021) (K Units)
    Table 26. Global Human Rabies Immune Globulin (HRIG) Sales Share by Type (2016-2021)
    Table 27. Global Human Rabies Immune Globulin (HRIG) Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2016-2021)
    Table 29. Human Rabies Immune Globulin (HRIG) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 30. Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Human Rabies Immune Globulin (HRIG) Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Human Rabies Immune Globulin (HRIG) Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Human Rabies Immune Globulin (HRIG) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 35. Global Human Rabies Immune Globulin (HRIG) Sales by Application (2016-2021) (K Units)
    Table 36. Global Human Rabies Immune Globulin (HRIG) Sales Share by Application (2016-2021)
    Table 37. Global Human Rabies Immune Globulin (HRIG) Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2016-2021)
    Table 39. Human Rabies Immune Globulin (HRIG) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 40. Global Human Rabies Immune Globulin (HRIG) Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Human Rabies Immune Globulin (HRIG) Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Human Rabies Immune Globulin (HRIG) Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Human Rabies Immune Globulin (HRIG) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 45. Japan Human Rabies Immune Globulin (HRIG) Sales (K Units) of Key Companies (2016-2021)
    Table 46. Japan Human Rabies Immune Globulin (HRIG) Sales Share by Company (2016-2021)
    Table 47. Japan Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) by Company (2016-2021)
    Table 48. Japan Human Rabies Immune Globulin (HRIG) Revenue Share by Company (2016-2021)
    Table 49. Japan Human Rabies Immune Globulin (HRIG) Sales (K Units) by Type (2016-2021)
    Table 50. Japan Human Rabies Immune Globulin (HRIG) Sales Share by Type (2016-2021)
    Table 51. Japan Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. Japan Human Rabies Immune Globulin (HRIG) Price (US$/Unit) by Type (2016-2021)
    Table 53. Japan Human Rabies Immune Globulin (HRIG) Sales (K Units) by Type (2022-2027)
    Table 54. Japan Human Rabies Immune Globulin (HRIG) Sales Share by Type (2022-2027)
    Table 55. Japan Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. Japan Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2022-2027)
    Table 57. Japan Human Rabies Immune Globulin (HRIG) Price (US$/Unit) by Type (2022-2027)
    Table 58. Japan Human Rabies Immune Globulin (HRIG) Sales (K Units) by Application (2016-2021)
    Table 59. Japan Human Rabies Immune Globulin (HRIG) Sales Share by Application (2016-2021)
    Table 60. Japan Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. Japan Human Rabies Immune Globulin (HRIG) Price (US$/Unit) by Application (2016-2021)
    Table 62. Japan Human Rabies Immune Globulin (HRIG) Sales (K Units) by Application (2022-2027)
    Table 63. Japan Human Rabies Immune Globulin (HRIG) Sales Share by Application (2022-2027)
    Table 64. Japan Human Rabies Immune Globulin (HRIG) Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. Japan Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2022-2027)
    Table 66. Japan Human Rabies Immune Globulin (HRIG) Price (US$/Unit) by Application (2022-2027)
    Table 67. North America Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021) & (K Units)
    Table 68. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2016-2021)
    Table 69. North America Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2016-2021)
    Table 75. Europe Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2016-2021)
    Table 77. Europe Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country (2016-2021)
    Table 87. CSL Behring Corporation Information
    Table 88. CSL Behring Description and Business Overview
    Table 89. CSL Behring Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 90. CSL Behring Human Rabies Immune Globulin (HRIG) Product
    Table 91. CSL Behring Recent Development
    Table 92. Grifols Corporation Information
    Table 93. Grifols Description and Business Overview
    Table 94. Grifols Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 95. Grifols Product
    Table 96. Grifols Recent Development
    Table 97. Sanofi Corporation Information
    Table 98. Sanofi Description and Business Overview
    Table 99. Sanofi Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 100. Sanofi Product
    Table 101. Sanofi Recent Development
    Table 102. Sichuan Yuanda Shuyang Corporation Information
    Table 103. Sichuan Yuanda Shuyang Description and Business Overview
    Table 104. Sichuan Yuanda Shuyang Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 105. Sichuan Yuanda Shuyang Product
    Table 106. Sichuan Yuanda Shuyang Recent Development
    Table 107. CNBG Corporation Information
    Table 108. CNBG Description and Business Overview
    Table 109. CNBG Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 110. CNBG Product
    Table 111. CNBG Recent Development
    Table 112. Kamada Corporation Information
    Table 113. Kamada Description and Business Overview
    Table 114. Kamada Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 115. Kamada Product
    Table 116. Kamada Recent Development
    Table 117. CBPO Corporation Information
    Table 118. CBPO Description and Business Overview
    Table 119. CBPO Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 120. CBPO Product
    Table 121. CBPO Recent Development
    Table 122. Shuanglin Bio Corporation Information
    Table 123. Shuanglin Bio Description and Business Overview
    Table 124. Shuanglin Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 125. Shuanglin Bio Product
    Table 126. Shuanglin Bio Recent Development
    Table 127. Weiguang Bio Corporation Information
    Table 128. Weiguang Bio Description and Business Overview
    Table 129. Weiguang Bio Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 130. Weiguang Bio Product
    Table 131. Weiguang Bio Recent Development
    Table 132. Shanghai RAAS Corporation Information
    Table 133. Shanghai RAAS Description and Business Overview
    Table 134. Shanghai RAAS Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 135. Shanghai RAAS Product
    Table 136. Shanghai RAAS Recent Development
    Table 137. Bharat Serum Corporation Information
    Table 138. Bharat Serum Description and Business Overview
    Table 139. Bharat Serum Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 140. Bharat Serum Product
    Table 141. Bharat Serum Recent Development
    Table 142. VINS Corporation Information
    Table 143. VINS Description and Business Overview
    Table 144. VINS Human Rabies Immune Globulin (HRIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 145. VINS Product
    Table 146. VINS Recent Development
    Table 147. Human Rabies Immune Globulin (HRIG) Market Trends
    Table 148. Human Rabies Immune Globulin (HRIG) Market Drivers
    Table 149. Human Rabies Immune Globulin (HRIG) Market Challenges
    Table 150. Human Rabies Immune Globulin (HRIG) Market Restraints
    Table 151. Human Rabies Immune Globulin (HRIG) Customers List
    Table 152. Human Rabies Immune Globulin (HRIG) Distributors List
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Rabies Immune Globulin (HRIG) Product Picture
    Figure 2. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type in 2020 & 2027
    Figure 3. 200IU Product Picture
    Figure 4. 500IU Product Picture
    Figure 5. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application in 2020 & 2027
    Figure 6. Category II Exposure
    Figure 7. Category III Exposure
    Figure 8. Human Rabies Immune Globulin (HRIG) Report Years Considered
    Figure 9. Global Human Rabies Immune Globulin (HRIG) Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Human Rabies Immune Globulin (HRIG) Market Size 2016-2027 (US$ Million)
    Figure 11. Global Human Rabies Immune Globulin (HRIG) Sales 2016-2027 (K Units)
    Figure 12. Global Human Rabies Immune Globulin (HRIG) Market Size Market Share by Region: 2021 Versus 2027
    Figure 13. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region (2016-2021)
    Figure 14. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Region in 2020
    Figure 15. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region (2016-2021)
    Figure 16. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region in 2020
    Figure 17. Global Human Rabies Immune Globulin (HRIG) Sales Share by Manufacturer in 2020
    Figure 18. The Top 10 and 5 Players Market Share by Human Rabies Immune Globulin (HRIG) Revenue in 2020
    Figure 19. Human Rabies Immune Globulin (HRIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 20. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type (2016-2021)
    Figure 21. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Type in 2020
    Figure 22. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type (2016-2021)
    Figure 23. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Type in 2020
    Figure 24. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application (2016-2021)
    Figure 25. Global Human Rabies Immune Globulin (HRIG) Sales Market Share by Application in 2020
    Figure 26. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application (2016-2021)
    Figure 27. Global Human Rabies Immune Globulin (HRIG) Revenue Market Share by Application in 2020
    Figure 28. Japan Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2016-2027 (K Units)
    Figure 29. Japan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 30. Japan Human Rabies Immune Globulin (HRIG) Market Share in Global Market 2016-2027
    Figure 31. Japan 5 and 10 Largest Human Rabies Immune Globulin (HRIG) Players Market Share by Revenue in Human Rabies Immune Globulin (HRIG) in 2020
    Figure 32. Japan Human Rabies Immune Globulin (HRIG) Revenue Share by Type (2016-2021)
    Figure 33. Japan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate by Type in 2016 & 2020
    Figure 34. Japan Human Rabies Immune Globulin (HRIG) Revenue Share by Application (2016-2021)
    Figure 35. Japan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate by Application in 2016 & 2020
    Figure 36. North America Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 37. North America Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 38. North America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2020
    Figure 39. North America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2020
    Figure 40. United States Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 41. United States Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Canada Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 43. Canada Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Europe Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 45. Europe Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 46. Europe Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2020
    Figure 47. Europe Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2020
    Figure 48. Germany Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 49. Germany Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 50. France Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 51. France Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. U.K. Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 53. U.K. Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. Italy Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 55. Italy Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. Russia Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Russia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 59. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 60. Asia Pacific Human Rabies Immune Globulin (HRIG) Sales Market Share by Region in 2020
    Figure 61. Asia Pacific Human Rabies Immune Globulin (HRIG) Revenue Market Share by Region in 2020
    Figure 62. China Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 63. China Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 64. Japan Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 65. Japan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. South Korea Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 67. South Korea Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. India Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 69. India Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. Australia Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 71. Australia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. China Taiwan Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 73. China Taiwan Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. Indonesia Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 75. Indonesia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Thailand Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 77. Thailand Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Malaysia Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Malaysia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Latin America Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 81. Latin America Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 82. Latin America Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2020
    Figure 83. Latin America Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2020
    Figure 84. Mexico Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 85. Mexico Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Brazil Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 87. Brazil Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Argentina Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 89. Argentina Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 90. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Growth Rate 2016-2021 (K Units)
    Figure 91. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 92. Middle East and Africa Human Rabies Immune Globulin (HRIG) Sales Market Share by Country in 2020
    Figure 93. Middle East and Africa Human Rabies Immune Globulin (HRIG) Revenue Market Share by Country in 2020
    Figure 94. Turkey Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 95. Turkey Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Saudi Arabia Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 97. Saudi Arabia Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. UAE Human Rabies Immune Globulin (HRIG) Sales Growth Rate (2016-2021) (K Units)
    Figure 99. UAE Human Rabies Immune Globulin (HRIG) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 100. Human Rabies Immune Globulin (HRIG) Value Chain
    Figure 101. Channels of Distribution
    Figure 102. Distributors Profiles
    Figure 103. Bottom-up and Top-down Approaches for This Report
    Figure 104. Data Triangulation
    Figure 105. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Frequently Asked Questions
Human Rabies Immune Globulin (HRIG) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Rabies Immune Globulin (HRIG) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Rabies Immune Globulin (HRIG) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Human Thrombin

Human Thrombin market is segmented by region (country), players, by Type, and by Application. Pla ... Read More

Rabies Antiserum

Rabies Antiserum market is segmented by region (country), players, by Type, and by Application. P ... Read More